These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23856147)

  • 21. Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models.
    Cole CH; Mitchell JP; Foley MP; Nagel MW
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F417-8. PubMed ID: 15321960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pressurized metered dose inhalers: optimal use of hydrofluoroalkane devices.
    Le Souëf PN
    Pediatr Pulmonol; 2001; Suppl 23():164-6. PubMed ID: 11886131
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
    Molimard M; Till D; Stenglein S; Singh D; Krummen M
    Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sub-micrometer particle production by pressurized metered dose inhalers.
    Crampton M; Kinnersley R; Ayres J
    J Aerosol Med; 2004; 17(1):33-42. PubMed ID: 15120011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.
    Papi A; Paggiaro P; Nicolini G; Vignola AM; Fabbri LM;
    Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
    Mogalian E; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing aerosol delivery by pressurized metered-dose inhalers.
    Rubin BK; Fink JB
    Respir Care; 2005 Sep; 50(9):1191-200. PubMed ID: 16122402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.
    Papi A; Paggiaro PL; Nicolini G; Vignola AM; Fabbri LM;
    Eur Respir J; 2007 Apr; 29(4):682-9. PubMed ID: 17107988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching to CFC-free beclometasone for asthma.
    Drug Ther Bull; 2008 Jun; 46(6):46-8. PubMed ID: 18525059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A switch to eco-friendly inhalers.
    Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):2. PubMed ID: 19370797
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy and safety of beclomethasone dipropionate HFA.].
    Capristo C; Rossi GA
    Recenti Prog Med; 2017 Nov; 108(11):1-11. PubMed ID: 29255325
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
    Rogueda PG; Price R; Smith T; Young PM; Traini D
    J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming dose-counting mechanisms on metered-dose inhalers for urgent treatment in the operating room.
    Templeton LB; Galyon SW; Smith TE
    Anesth Analg; 2009 Nov; 109(5):1709-10. PubMed ID: 19843820
    [No Abstract]   [Full Text] [Related]  

  • 38. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.
    Price D; Thomas M; Haughney J; Lewis RA; Burden A; von Ziegenweidt J; Chisholm A; Hillyer EV; Corrigan CJ
    Respir Med; 2013 Jul; 107(7):987-1000. PubMed ID: 23643486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is inhaled beclomethasone (BDP) with a non-CFC propellant equivalent to the CFC propellant formulations?
    Chrystyn H
    Respir Med; 2000 Feb; 94(2):177-9; author reply 179-80. PubMed ID: 10714428
    [No Abstract]   [Full Text] [Related]  

  • 40. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.
    Tashkin DP
    Expert Rev Respir Med; 2010 Dec; 4(6):703-14. PubMed ID: 21128746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.